We provide diagnostic, prognostic, and predictive answers to cancer testing to empower the best possible care for your patients.
Personalized patient care starts with precision oncology.
Sophisticated diagnostic testing is how we enable you to deliver precision oncology to your patients. Our comprehensive testing menu of over 500+ tests encompasses all major testing methodologies – flow cytometry, FISH, cytogenetics, and targeted or broad-panel DNA- and RNA-based next-generation sequencing (NGS) – for tissue-based and liquid biopsy testing of solid tumor and hematologic cancers. NGS provides the resolution to detect targetable biomarkers and identify the driving mechanism behind your patient’s cancer, with the added benefit of revealing clinical trial opportunities and eligibility. Identifying the right test doesn’t have to be complicated. We simplify your ordering process with expertly designed single-order products, like NeoTYPE® Cancer Profiles – a unique offering that ranges from broad-spectrum pan-tumor profiling to disease-specific testing, harnessing the power of NGS.
InVisionFirst®-Lung
InVisionFirst®-Lung
ctDNA liquid biopsy for advanced non-small cell lung cancer (NSCLC)
InVisionFirst®-Lung liquid biopsy is a focused 37-gene panel that covers the guideline recommended biomarkers to help inform diagnosis and progression of NSCLC patients.
NEW
KRAS G12C
One of the most prevalent biomarkers in non-small cell lung cancer (NSCLC).
KRAS mutations are common oncogenic drivers in NSCLC and generally exclusive of other driver mutations in genes such as EGFR, ALK, and ROS1.4 KRAS mutations are often early truncal mutations that can persist during disease progression.
NeoTYPE® Cancer Profiles
NeoTYPE® Cancer Profiles for hematologic and solid tumor malignancies
NeoTYPE® Cancer Profiles offer two unique levels of molecular profiling services that center on NGS based testing; both broad and targeted profiles are available.
COMPASS®
COMPASS® Hematopathology Services
Clear and comprehensive diagnostic solution is the foundation for the best patient care.
COMPASS® is a streamlined, board-certified hematopathologist directed approach that provides an accurate, actionable and definitive diagnosis for complex hematologic malignancies.
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients